High caffeine levels associated with weight loss and type 2 diabetes risk: BMJ

Published Date: 17 Mar 2023

UK: A recent study published in BMJ Medicine found that more caffeine in the blood can reduce the risk of type 2 diabetes and obesity. more...

Read Full News

Latest News

Faricimab Reduces Shots, Improves Vision for Retinal Disease

In two studies in retinal disease, faricimab shows improved vision and a reduced injection burden in people who switched from first-generation drugs.

Food Addiction Can Derail Success After Bariatric Surgery

Following bariatric surgery, women with food addiction report a higher intake of ultraprocessed foods, greater anxiety, lower physical activity, and less favorable weight-loss outcomes.

Will Semaglutide Prices Drop After 2026 Patent Expirations?

As patents expire, generic injectable semaglutide could become available at a fraction of current branded prices — around $28-$140 per person-year — in about 162 countries by the end of 2026.

Helping Patients With Diabetes Utilize Technology

Helping patients overcome fear or anxiety around continuous glucose monitoring may be a hurdle.

Novo Sues Lilly, Claiming Misleading Ads in Weight-loss Drug Battle

Novo Nordisk sued rival Eli Lilly in a U.S. federal court on Tuesday, accusing the U.S. drugmaker of false advertising in claiming its weight-loss medicines outperform...

Global Trial to Test Lifestyle Plus Metabolic Tx in Dementia

A $100 million global trial will investigate whether adding a metabolism-targeting therapy to multidomain lifestyle intervention further reduces the risk of cognitive decline in older adults at risk for dementia.

Todays Updates

In SCLC, Radiotherapy Plus Immunotherapy Ups Fatal Events

A lung cancer trial was stopped early due to a high rate of fatal adverse events with the addition of thoracic radiotherapy to standard maintenance immunotherapy.

Smoldering Myeloma: The Treatment Issue Is Getting Trickier

An FDA approval, striking CAR T data, and a field that can't agree on what to do next. Experts weigh in on the most contentious question in myeloma.

Todays Updates

In SCLC, Radiotherapy Plus Immunotherapy Ups Fatal Events

A lung cancer trial was stopped early due to a high rate of fatal adverse events with the addition of thoracic radiotherapy to standard maintenance immunotherapy.

Smoldering Myeloma: The Treatment Issue Is Getting Trickier

An FDA approval, striking CAR T data, and a field that can't agree on what to do next. Experts weigh in on the most contentious question in myeloma.

Latest News

In two studies in retinal disease, faricimab shows improved vision and a reduced injection burden in people who switched from first-generation drugs.

Following bariatric surgery, women with food addiction report a higher intake of ultraprocessed foods, greater anxiety, lower physical activity, and less favorable weight-loss outcomes.

As patents expire, generic injectable semaglutide could become available at a fraction of current branded prices — around $28-$140 per person-year — in about 162 countries by the end of 2026.

Helping patients overcome fear or anxiety around continuous glucose monitoring may be a hurdle.

Novo Nordisk sued rival Eli Lilly in a U.S. federal court on Tuesday, accusing the U.S. drugmaker of false advertising in claiming its weight-loss medicines outperform...

A $100 million global trial will investigate whether adding a metabolism-targeting therapy to multidomain lifestyle intervention further reduces the risk of cognitive decline in older adults at risk for dementia.

News All Time

Managing Diabetes and HIV Together: What to Know

As people with HIV live longer, diabetes is becoming an increasingly important contributor to morbidity and mortality, requiring specialized management approaches.

GLP-1s May Reduce Overdose Risk, Even After Discontinuation

People with a history of alcohol, opioid, or substance overdose who are later started on GLP-1 medications have a significantly lower risk for a repeat overdose.

South Africa's IDexis Appeals Court Ruling Over Compounded Weight-loss Drugs

South African pharmacy group iDexis said on Tuesday it had applied to appeal a court judgment that curbed its production ⁠of compounded weight-loss medicines, disputing...

Study Flags Need to Monitor Frailty Risks With GLP-1 Drugs for Older Adults

Potential signs of frailty in older adults taking Eli Lilly’s GLP-1 obesity drug Zepbound may signal relatively high risks for adverse outcomes, according to a large study...

Merck Gets US FDA Nod for First-in-its-class Oral Cholesterol Drug

The U.S. FDA approved Merck's cholesterol-lowering pill, it said on Thursday, the first in a class of drugs dominated ⁠by injections, which could potentially broaden the use...

Do Infant Food Portion Sizes Matter for Later Overweight?

Larger food portions during complementary feeding are associated with higher odds of overweight in both early and later childhood.

Semaglutide Linked to Rare Brain Illness

In rare cases, semaglutide for obesity is linked to Wernicke encephalopathy, driven by gastrointestinal intolerance, reduced nutritional intake, and rapid weight loss leading to thiamine deficiency.

Screening for Diabetes at Urgent Care Could Save Lives

Millions of Americans have diabetes or prediabetes. Simple screening at urgent care could change their futures.

Women Wait Longer Than Men for a Thyroid Disease Diagnosis

Some symptoms of hypothyroidism and hyperthyroidism overlap with those of other conditions and diseases, which makes differential diagnosis challenging.

Two Dietary Fibers May Cut Crohn’s Risk in Certain Patients

Eating more dietary fibers such as beta-glucan and inulin is linked to a lower risk for Crohn’s disease in first-degree relatives of patients with Crohn’s disease.

Androgen Blood Test May Help Diagnose Endometriosis

Women with endometriosis show a distinct blood androgen profile that distinguishes them from women without the disease, pointing to a possible future noninvasive test.

Ovarian Cancer: Can Repurposed Drugs Work Better Together?

A preclinical study finds that combining atovaquone with platelet-derived growth factor receptor inhibitors reduced ovarian cancer tumoroid viability.

First Non-Hormonal Menopause Drug Approved in Scotland

The Scottish Medicines Consortium has accepted fezolinetant for restricted use within NHS Scotland for menopausal vasomotor symptoms in women who cannot take hormone therapy.

Acromegaly Tied to Elevated Colorectal, Thyroid Cancer Risk

Acromegaly is tied to a higher risk for colorectal cancer and benign colorectal lesions, but the overall long-term cancer risk and cancer-related mortality remain comparable to the general population.

Guidance Aids Adjunctive Incretin Use in Type 1 Diabetes

Positive findings from a phase 2 trial were followed by disappointing news; however, new guidelines aim to help clinicians with off-label prescribing.

Can Sniffing Chocolate Boost Leg Workout Performance?

Sniffing chocolate before performing sets of leg extensions may modulate appetite and increase overall training volume without raising perceived exertion.

Recommended News For You

Metastatic Cancer 'Thrivers'; Celebrity Cancer Diagnoses; 'Would He Have Lived?'

Could the Prostate Cancer Story of Francis Collins Dissuade Men from Active Surveillance?

First-Line HCC Trial's Lenvatinib-Pembrolizumab Combo Misses Target.

Prostate cancer Q&A: Improving detection and reducing overtreatment

'Sugar' signatures help identify and classify pancreatic cancer cell subtypes

Research suggests peer support may lower depression, stress among cancer patients in low-resource settings

Parkinson patient's gait is restored by a spinal cord stimulator.

Recommended Articles For You

Case Study: Combining Targeted Therapy with Immunotherapy for Metastatic Melanoma 

Uncovering New Hope for Follicular Lymphoma Patients 

Gut microbiota in curing cancer 

Pharmacological Frontier of Precision Oncology, Immunotherapies, and the Evolving Art of Treatment 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Food insecurity linked to tumor growth in pediatric neuroblastoma

2.

New imaging guidelines for head and neck cancers, a step toward practice change

3.

Rural residents continue to have higher odds of skin cancer, study finds

4.

24 months after radical prostateectomy, no PSA recurrence was observed when using apalutamide plus ADT.

5.

Is Exercise an Effective Treatment for Prostate Cancer?

1.

Dexamethasone and Life Expectancy After Pediatric Stem Cell Transplant

2.

The Miracle of Thyrogen Injection: A New Hope for Thyroid Cancer Treatment

3.

AI-Driven Chemotherapy: Transforming Cancer Care with Precision and Efficiency

4.

The Truth About Marijuana and Its Effect on Mental Health 

5.

Understanding Mantle Cell Lymphoma Prognosis.

1.

Asian Symposium on Advancement in Hematology and Oncology

2.

Asian Symposium on Advancement in Hematology and Oncology

3.

Asian Symposium on Advancement in Hematology and Oncology

4.

International Cancer Conference

5.

Asian Symposium on Advancement in Hematology and Oncology

1.

A Conclusive Discussion on CROWN Trial and the Dawn of a New Era in Frontline Management of ALK+ NSCLC

2.

A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part VI

3.

Pazopanib Takes Center Stage in Managing Renal Cell Carcinoma - Part V

4.

Breaking Ground: ALK-Positive Lung Cancer Front-Line Management - Part II

5.

Updates on the First Line Management of ALK+ NSCLC

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot